US 10314904
Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10314904 (Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K2039/55